HomeNews & TopicsResearchMcGill team pinpoints where a type of cell death begins

McGill team pinpoints where a type of cell death begins

Published on

A team at McGill University studying ferroptosis, a form of cell death, have discovered that the process begins deep inside the cell, a finding that could lead to new treatments for cancer and neurodegenerative diseases.

Using antioxidant probes that light up as they are consumed, the team tracked ferroptosis in real time and identified the endoplasmic reticulum (ER) as the key cellular structure where the process first takes hold. Protecting the ER and the lysosome, they found, can halt ferroptosis entirely.

“Ferroptosis has therapeutic potential in cancer treatment and neurodegenerative diseases,” said Gonzalo Cosa, professor in McGill’s Department of Chemistry and senior author on the study. “But until now, we didn’t know how it starts or propagates. This information is critical toward understanding the action of current ferroptosis inducers and inhibitors.”

“Our results show that protecting the ER and lysosomes can abort ferroptosis,” said Cosa. “In contrast, protecting the outer leaflet of the plasma membranes does not impact ferroptosis evolution.”

Implications for cancer, neurodegenerative disorders

Ferroptosis kills cells by triggering runaway chemical reactions that damage fats in cell membranes. In cancer, deliberately triggering ferroptosis could stop tumour growth. In Alzheimer’s, Parkinson’s and other conditions, slowing down ferroptosis could protect healthy brain cells.

“Understanding the molecular action of new forms of cell death is critical in health,” said Cosa. “Such an understanding paves the way for the development of better therapies.”

A new window into cell death

The researchers’ custom-built fluorogenic antioxidants acted as beacons, revealing when and where in the cell, lipid damage began. The research work offers a powerful new platform to study drugs designed to either block or induce ferroptosis.

“These antioxidants further enable enhanced resolution and visualization of the evolution of this form of cell death, providing unprecedented molecular information at the cellular level,” said Cosa.

Latest articles

New approach opens door to better-targeted treatments and faster drug discovery for complex diseases

McGill researchers have developed an AI tool called SIDISH that identifies high-risk cancer cells driving aggressive disease, enabling more precise and targeted treatment strategies. By linking single-cell data with patient outcomes, the tool can predict disease progression and simulate responses to potential drug targets, helping accelerate drug discovery and repurposing. While still in development, SIDISH shows promise for advancing personalized cancer care and improving outcomes across multiple tumour types.

Canadian Cancer Society urges lowering colorectal cancer screening age to 45

The Canadian Cancer Society is urging provinces to lower the colorectal cancer screening age from 50 to 45, citing rising rates among younger adults and evidence that earlier screening could prevent over 15,000 cases and 6,100 deaths. Younger patients are more often diagnosed at advanced stages, making early detection critical. Expanding access to simple screening tools like FIT tests could significantly improve outcomes and save lives.

Unleashing natural killer cells against cancer

Researchers at McGill University have developed a new strategy to enhance natural killer (NK) cells, enabling them to better penetrate tumour defenses and destroy cancer cells. Using small-molecule drugs to temporarily boost NK cell activity—rather than permanent genetic modification—the approach showed strong results against multiple hard-to-treat cancers in preclinical studies. The scalable, ready-to-use therapy could make immunotherapy faster, safer, and more accessible, with future clinical trials planned for aggressive cancers like acute myeloid leukemia.

Doctors report false health information, lack of health data sharing put patient care at risk

A new CMA survey reveals major risks to patient care in Canada, with 99% of physicians reporting that disconnected health systems limit access to critical patient information and nearly half witnessing serious adverse outcomes as a result. At the same time, 97% of doctors say they have intervened to address harm caused by false or misleading online health information, including AI-generated advice. The findings highlight the urgent need for integrated digital health systems and stronger efforts to promote reliable health information.

More like this

RSV hospital admissions for children more than doubled in 2022/23

New Canadian research shows pediatric RSV hospitalizations more than doubled in 2022/23 compared to pre-pandemic levels, with significant increases across all age groups and nearly one-quarter requiring ICU care. Infants under six months remain the most vulnerable, accounting for the majority of severe cases. The surge is linked to disrupted virus exposure during COVID-19, highlighting the importance of new prevention strategies, including maternal vaccination and infant immunoprophylaxis.

Navigating breastfeeding after spinal cord injury

HN Summary • New research shows spinal cord injuries can disrupt breastfeeding due to physiological...

First-in-Canada case of sustained HIV remission

HN Summary • A first-in-Canada case shows a patient achieving sustained HIV remission following a...

UHN researchers investigate new therapies as colon cancer rises among young patients

HN Summary • Colorectal cancer is rising among younger adults, prompting UHN researchers to investigate...

HHS lung cancer patient thrives thanks to research trial

HN Summary • A Nurse Practitioner (NP) pilot in Niagara Health’s ED has significantly reduced...

New Research at University of Alberta Advances Fight Against Parkinson’s Disease

Researchers at the University of Alberta are reporting new progress in understanding and potentially...